Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management

Genes (Basel). 2022 Oct 17;13(10):1880. doi: 10.3390/genes13101880.

Abstract

Hereditary metabolic bone diseases are characterized by genetic abnormalities in skeletal homeostasis and encompass one of the most diverse groups among rare diseases. In this review, we examine 25 selected hereditary metabolic bone diseases and recognized genetic variations of 78 genes that represent each of the three groups, including sclerosing bone disorders, disorders of defective bone mineralization and disorder of bone matrix and cartilage formation. We also review pathophysiology, manifestation and treatment for each disease. Advances in molecular genetics and basic sciences has led to accurate genetic diagnosis and novel effective therapeutic strategies for some diseases. For other diseases, the genetic basis and pathophysiology remain unclear. Further researches are therefore crucial to innovate ways to overcome diagnostic challenges and develop effective treatment options for these orphan diseases.

Keywords: achondroplasia; hereditary connective tissue disorder; hypophosphatasia; hypophosphatemic rickets; metabolic bone disease; osteogenesis imperfecta; osteopetrosis; sclerosing disorders; vitamin D-dependent rickets.

Publication types

  • Review

MeSH terms

  • Bone Diseases, Metabolic* / diagnosis
  • Bone Diseases, Metabolic* / genetics
  • Bone Diseases, Metabolic* / therapy
  • Humans
  • Rare Diseases / diagnosis
  • Rare Diseases / genetics
  • Rare Diseases / therapy

Grants and funding

This research received no external funding.